GlassScriptPhysician profile
Elizabeth M Tieu
NPI 1487357224
$376.96
in general payments reported to CMS, 2019-2025
12 companies · $69.22 in 2025
The $69.22 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $203 · 2024: $104 · 2025: $69.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $60.38 | 2023-2024 | Immunocap |
| Cumberland Pharmaceuticals, INC. | $48.04 | 2023 | Kristalose |
| Boston Scientific Corporation | $36.88 | 2025 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $35.31 | 2023-2024 | |
| Novo Nordisk INC | $32.34 | 2025 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $32.11 | 2023 | Dupixent |
| Sanofi Pasteur INC. | $26.89 | 2023 | |
| Amgen INC. | $24.64 | 2024 | Prolia, Evenity |
| Noven Therapeutics, LLC | $23.92 | 2024 | Xelstrym |
| Hologic Sales and Service, LLC | $21.86 | 2023 | Aptima |
| Glaxosmithkline, LLC. | $18.69 | 2024 | Shingrix, Arexvy |
| Verrica Pharmaceuticals INC. | $15.90 | 2023 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Tieu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.